Vimarsana
Biggest News Aggregation in the World

Orbimed Advisor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Orbimed Advisor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Orbimed Advisor Today - Breaking & Trending Today

10 Best Biotech Stocks Under $10 - Insider Monkey - Vimarsana News

10 Best Biotech Stocks Under $10 - Insider Monkey

In this article, we will take a look at the 10 best Biotech stocks under $10.

Top 5 Stock Picks of Samuel Isaly's OrbiMed Advisors - Vimarsana News

Top 5 Stock Picks of Samuel Isaly's OrbiMed Advisors

In this article, we will discuss the top 5 stock picks of Samuel Isaly's OrbiMed Advisors.

Top 10 Stock Picks of Samuel Isaly's OrbiMed Advisors - Vimarsana News

Top 10 Stock Picks of Samuel Isaly's OrbiMed Advisors

In this article, we discuss the top 10 stock picks of Samuel Isaly's OrbiMed Advisors.

Spokane Employees pulls $5 million investment from OrbiMed - Vimarsana News

Spokane Employees pulls $5 million investment from OrbiMed

Spokane Employees' Retirement System redeemed its $5 million investment in OrbiMed Advisors' long-biased health-care strategy.

1Globe Capital, the Largest Shareholder of Sinovac Biotech, Reached Agreement with SEC and Calls on All Stakeholders to Support Sinovac's COVID-19 Vaccine Program - Vimarsana News

1Globe Capital, the Largest Shareholder of Sinovac Biotech, Reached Agreement with SEC and Calls on All Stakeholders to Support Sinovac's COVID-19 Vaccine Program

Share: BEIJING and BOSTON, Dec. 23, 2020 (GLOBE NEWSWIRE) -- 1Globe Capital LLC ("1GlobeCap"), a principal and long-term shareholder of Sinovac Biotech (NASDAQ:SVA) ("Sinovac"), has reached agreement with the Securities and Exchange Commission ("SEC") to end investigation of its 13D form compliance. During this critical phase of vaccine and therapeutics development for the ongoing pandemic, 1GlobeCap felt it was important to focus on its many projects, which include the development of COVID-19 therapeutics and vaccines. For this reason, 1GlobeCap decided to accept a SEC settlement offer, in...